Key indicators: single-crystal X-ray study; T = 295 K; mean (C-C) = 0.006 Å; Hatom completeness 89%; disorder in solvent or counterion; R factor = 0.057; wR factor = 0.210; data-to-parameter ratio = 16.2.
The title compound, {[Zn(C 14 H 16 N 5 O 3 ) 2 ]Á2H 2 O} n or [Zn(ppa) 2 ]Á2H 2 O} n , where ppa = 8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)-pyrido(2,3-d)-pyrimidine-6-carboxylate, was synthesized under hydrothermal conditions. The Zn II atom (site symmetry 1) exhibits a distorted trans-ZnN 2 O 4 octahedral geometry defined by two monodentate N-bonded and two bidentate O,O-bonded ppa monoanions. The extended two-dimensional structure arising from this connectivity is a square grid and the disordered uncoordinated water molecules occupy cavities within the grid. An N-HÁ Á ÁO hydrogen bond occurs.
Related literature
For manganese complexes of the ppa anion, see: Huang et al. (2008) . For background to the medicinal uses of pipemidic acid, see: Mizuki et al. (1996) .
Experimental
Crystal data [Zn(C 14 Table 1 Selected bond lengths (Å ).
Table 2
Hydrogen-bond geometry (Å , ). The water H atoms could not be placed due to the disorder of the O atoms. supplementary materials
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